-I assume you mean higher number of pregnancies and these are only risk factors from one study and therefore not really generalisable. Table 2 -it seems to me that you won't need to ask all these questions every three months ie. Race. Perhaps you need a baseline form and then follow up form. It is also unclear how you are going to measure 'limitation of ankle movement'. What if a patient doesn't have a chart entry every three months? Will this always include height and weight? Interest to readers This is an interesting subject area and will be of great benefit to clinicians and researchers and has the potential to make huge additions to our knowledge.
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GENERAL COMMENTS
1. The study is an ambitious one but its claims understate what is already known and done and the methodology simplifies the task if it is to achieve the new knowledge aimed for and to meaningfully take into account the many variables and factors at play in the cohort envisaged 2. Regarding the documentation of the development of fVLU after the diagnosis of CVI on venous duplex. Venous duplex does not diagnose CVI. CVI is a clinical diagnosis and duplex is an adjunctive investigation which may reflect some causes.
3. If the aim is to identify the risk factor for first ulcer in patients with CVI -can this study take into account prior treatment and ongoing treatment. Presumably treatment will be ongoing during the observation period and this treatment will have the intention to prevent VLU Of those who have a duplex most are done presumably for treatment to correct the abnormal venous finding (usually reflux) -therefore most will have treatment which is also by implication the same treatment to avert first VLU.
Would it not be better to study a cohort who have not been treated?
4. If the intent is to identify factors for primary prevention -have the authors envisaged what these might be from the factors they are collecting data for. Don't we already know these from many studies for CVI and how would they use these for primary prevention?
5. The numbers are based on 5 year past and 5 year future duplex scans (2500 x 2). In getting these numbers the authors must have some estimate of what proportion of these will meet the criteria by electronic search of their data base.e.g this reviewer would presume that the authors lab collects data at the time of the duplex of e.g prior VLU, age, etc
6. It appears that most of the prior data will be obtained without seeing the patient -it would be important to know how the authors 13. The authors define "Reflux is defined as retrograde blood flow in the lower extremities greater than 0.5 seconds while in the reverse Trendelenburg position without provocation. This is not correct. Provocation is required to demonstrate the reverse flow. It also neglects that 0.5s is not considered to be the time to define significant reflux across all segments of the venous system of the lower limb.
14. In the introduction the authors also suggest " The pathophysiology of VLU remains unclear." This is not true -there is a great deal known and an extensive literature. What they suggest as being "hypotheses" are well established observations that contribute to the progression of the pathophysiology of VLU. Quality of presentation A thorough proof read of the article would be beneficial. There are some minor grammar issues that could easily be addressed with a thorough read.
REVIEWER

Scientific Soundness
Introduction -Definition of reflux needs to be referenced. A reference has been added.
Good background and rationale.
Rationale -last sentence that discusses your primary aim. I think your primary aim should be to determine risk factors for development of a fVLU that will then lead to your interventions. We agreethis sentence has been revised.
Page 9, third sentence -I don't think queried is the right word We double checked -this is appropriate terminology ("to query a database")
Study design -where you have 'see below for details', I'd be more specific as it is unclear where to look. This has been clarified.
You say here that there is no pre-determined stop date although in other areas of the paper you say 5 years. This has been clarified in the section "study design -overview." We will follow all patients for up to 5 years. We also plan to enroll patients for 5 years. However, depending on resources, we may seek to keep enrolling new subjects beyond the 5 year mark.
The study protocol is to follow patients up every three months however this has obviously not been done for patients from 2011. The retrospective data collection and management may be worth discussing. The retrospective part of the study applies to people already in the database. However, the same initial assessment data collection form is used whether the duplex study occurred in the past or present. Time zero for this study is the duplex study date. From the present, we will then follow up with patients every 3 months. Please see sections "study design overview" and "end point and follow up."
You say that photos are not part of the study protocol and therefore it is unclear whether you have ethical approval for this and how you will ensure confidentiality of this data being sent through by email. Do you have an ethics approval number? The photo step is an approved aspect of the protocol. It is an optional step, as not all patients may be able to provide a photo. Any email correspondence will be through secure email. This has been clarified in the section "evaluation of study endpoint -photo of wound," and a sentence has been added to the section "ethical aspects" noting that all aspects of the study are IRB approved.
Discussion -I don't think develop a cohort is the right word Table 1 -I assume you mean higher number of pregnancies and these are only risk factors from one study and therefore not really generalisable. The citation is from a single comprehensive review, but the risk factors are based on findings from many studies. The table has been changed to "Higher number of pregnancies" Table 2 -it seems to me that you won't need to ask all these questions every three months ie. Race. Perhaps you need a baseline form and then follow up form. This is correct -we actually do have a separate form for initial assessment and follow up. Unchanging variables such as height or race will not be included in the follow up. Text has been added to the section "Data collection and management" that notes this.
It is also unclear how you are going to measure 'limitation of ankle movement'. What if a patient doesn't have a chart entry every three months? Will this always include height and weight? This question, like others in this study, is subjective only. If the answer is "yes," then we ask follow up questions as to the reason for limitation in movement, i.e. rheumatoid arthritis, osteoarthritis, history of broken foot, etc. We will use the most recent weight from the chart (height will only be asked on initial assessment) for follow ups.
Interest to readers This is an interesting subject area and will be of great benefit to clinicians and researchers and has the potential to make huge additions to our knowledge.
Reviewer: 2 Reviewer Name: Andre van Rij Institution and Country: University of Otago, New Zealand Please state any competing interests or state 'None declared': no conflict of interests Please leave your comments for the authors below 1. The study is an ambitious one but its claims understate what is already known and done and the methodology simplifies the task if it is to achieve the new knowledge aimed for and to meaningfully take into account the many variables and factors at play in the cohort envisaged 2. Regarding the documentation of the development of fVLU after the diagnosis of CVI on venous duplex. Venous duplex does not diagnose CVI. CVI is a clinical diagnosis and duplex is an adjunctive investigation which may reflect some causes. We agree that CVI is a clinical diagnosis. However, for the purposes of research, duplex ultrasound is reliable and reproducible measurement that can objectively document venous insufficiency. The perfect study would involve CVI experts evaluating a true random population based sample of thousands of individuals for signs of CVI, yet this is not feasible. While 100% of patients with CVI will not have reflux on duplex study, the vast majority of these people with signs of CVI will have reflux on duplex ultrasound.
3. If the aim is to identify the risk factor for first ulcer in patients with CVI -can this study take into account prior treatment and on-going treatment Presumably treatment will be ongoing during the observation period and this treatment will have the intention to prevent VLU Of those who have a duplex most are done presumably for treatment to correct the abnormal venous finding (usually reflux) -therefore most will have treatment which is also by implication the same treatment to avert first VLU.
Yes, this study takes into account all aspects of treatment, including leg elevation, compression, medications, and surgical treatment (specific procedure and date). All of these details are included in data collection.
We have chosen to be inclusive in this initial study, as this will provide a richer dataset. Moreover, presumably leg elevation at night is a treatment -this is anyone who sleeps in a bed. We are keeping track of all interventions and their exact timing.
4. If the intent is to identify factors for primary prevention -have the authors envisaged what these might be from the factors they are collecting data for. Don't we already know these from many studies for CVI and how would they use these for primary prevention? We know risk factors for CVI, yet we do not actually know risk factors the first VLU. Why one third of Americans have CVI yet only ~1% develop VLUs is unknown. We also have no way to predict who will go on to develop ulcers. There is presumably significant overlap in CVI and VLU risk factors, but current approaches to prevention are not satisfactory. Thus, we are collecting data broadly in an attempt to tease these differences out. These ideas are elaborated in the introduction.
5. The numbers are based on 5 year past and 5 year future duplex scans (2500 x 2). In getting these numbers the authors must have some estimate of what proportion of these will meet the criteria by electronic search of their data base.e.g this reviewer would presume that the authors lab collects data at the time of the duplex of e.g prior VLU, age, etc 2500 have reflux in the past 5 years. A small number will have had prior VLU or not be between 18-95 years old. The proportion to meet criteria will be very high, though there is no way for us to pre-filter out people who do not meet criteria.
6. It appears that most of the prior data will be obtained without seeing the patient -it would be important to know how the authors will verify the clinical signs. Telephone enquiry is not adequate to have confidence needed for the analysis. We will ask the patient some questions that are subjective and cannot be verified. This is a limitation of this study. However, we will verify data, including medical history and medications, whenever possible in the patient chart. At baseline, we will already know the patient has real venous reflux and know the indication for the study -usually leg edema, varicosities, or pain.
7. Hospital records will be perused -will these be available across the hospitals. Will family doctor records be considered relevant? How reliable are these for the clinical detail required? The electronic record includes notes from everyone seen within the University of Miami Hospital System, which includes all levels of care. The entirety of the patient chart will be considered. Notes are reliable to the extent of documentation and patient interview. Sensitivity might be low in certain cases, but this is a limitation of the study that we must accept. Moreover, this is the issue with purely using the patient chart and underscores the importance of patient telephone interview.
8. Ulcer photographs are these available for all -if not how will these be obtained , how will they be evaluated ? The photograph is an optional step, as not all patients may be able to provide a photo. Any email correspondence will be through secure email. We developed a protocol for evaluating images received. This will involve independent evaluation by two investigators. They will first confirm presence of a wound, then determine if this can be considered a VLU: yes, no, or difficult to determine. In cases of disagreement, the case will be presented to a third wound expert (RSK) for final determination. Subjects will then be encouraged to see us in clinic.
This has now been clarified in the section "evaluation of study endpoint -photo of wound"
9. Why is written consent not to be obtained. What will the verbal process be ? Some detail is required. a A sentence has been added to the section "ethical aspects" noting that all aspects of the study as outlined in this manuscript are IRB approved. Written consent is not feasible or indicated, as this study consists primarily of chart review and a telephone interview. The
